Approval · Notice of Compliance 5938 · 2004
PREVACID: Notice of Compliance 5938
Issued November 30, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5938
- Date
- November 30, 2004
- Company
- Tap Pharmaceuticals, Inc.Lake Forest, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for an additional dosage form: granules for delayed release oral suspension
- Therapeutic class
- H+, k+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREVACID | 02258609 | — |
| PREVACID | 02258617 | — |
Medicinal ingredients
- LANSOPRAZOLE 15 MG per DOSE
- LANSOPRAZOLE 30 MG per DOSE